Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma
eribulin mesIlate
E7389-J081-217
NCT01458249
Soft Tissue Sarcoma
Phase 2
 
No restrictions. Note: Japan is the only country participating in this study.
November 2017

Powered by ideaPoint, Inc.